Drug Coated PTA Balloon Catheter

OVERVIEW

Drug Coated Ballon PTA Catheter

ENSURE EFFECTIVE DRUG DELIVERY OF A SAFE THERAPEUTIC DOSAGE

The drug eluting balloon catheter, a versatile and effective PAD treatment option, features unique Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.

Product Features

Drug Coated PTA Paclitaxel Balloon Catheter

A carrrier or an excipient is not always necessary

Coating Technology

01

The DCB drug dose of paclitaxel is 3μg/mm².

02

UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.

03

Particle size distribution test results show that 75% of the particles related are in 5-10μm range.

04

The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.

05

UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.

06

The effective drug tissue concentration at the lesion site lasts for more than 90 days.

More options with the clinically proven platforms

The DCB is based upon the PTA balloon platform and features

Low entry profile and excellent crossability

Advanced pushability

Long balloon lengths up to 220mm

INDICATIONS

Drug Coated Balloon Catheter

The ZENFLUXION™ Drug-coated PTA Balloon Catheters are indicated for Percutaneous Transluminal Angioplasty (PTA) of stenosis or occlusion lesions in iliac, femoral or popliteal arteries.

If you want to know more about tonbridge news live, please visit our website.